| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 39IS23Q1EW |
| InChI Key | VUDZSIYXZUYWSC-DBRKOABJSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.22 |
| AlogP | -1.57 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 102.26 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 18.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Cytidine deaminase inhibitor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Lymphoma, T-Cell, Peripheral | 1 | D016411 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
| Carcinoma, Squamous Cell | 1 | D002294 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Leukemia, Myeloid | 1 | D007951 | ClinicalTrials |
| Mastocytosis, Systemic | 1 | D034721 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3237547 |
| DrugBank | DB15694 |
| FDA SRS | 39IS23Q1EW |
| Guide to Pharmacology | 11101 |
| PubChem | 25267009 |
| SureChEMBL | SCHEMBL172256 |
| ZINC | ZINC000043205136 |